Why do older women delay presentation with breast cancer symptoms?

Psycho-oncology
C C BurgessA J Ramirez

Abstract

Women who delay their presentation with breast cancer for three months or longer are more likely to be diagnosed with later stage disease and have poorer survival. Older women, who are at greater risk of developing breast cancer, are also more likely to delay their presentation. Factors associated with delayed presentation were assessed in 69 women (>65 years) with breast cancer. Previous factors identified for women of all ages were confirmed (having a non-lump symptom p=0.003) or strengthened (non-disclosure of symptom discovery to a relative or close friend p=0.001). Additional factors for delay in this older group included reservations about seeing their GP (p=0.02) and fear of the consequences of cancer (p=0.04). These factors should inform the design of interventions to reduce delays.

References

May 18, 1988·Journal of the National Cancer Institute·J M SametJ S Goodwin
Aug 15, 1985·American Journal of Obstetrics and Gynecology·L D DevoeD M Sherline
Jul 1, 1994·Journal of Biopharmaceutical Statistics·R C Schoemaker, H C van Houwelingen
May 14, 1998·British Journal of Cancer·C C BurgessS B Love
Aug 13, 1999·BMJ : British Medical Journal·K Gardner, A Chapple
Sep 8, 2000·BMJ : British Medical Journal·K McPhersonJ M Dixon
Sep 22, 2000·BMJ : British Medical Journal·J R SainsburyD A Morgan
Jan 6, 2001·Family Practice·C ShawR Allan
May 3, 2002·British Journal of Cancer·E A GrunfeldM A Richards
Feb 8, 2003·Journal of Psychosomatic Research·Elizabeth A GrunfeldMichael A Richards

❮ Previous
Next ❯

Citations

Mar 6, 2009·Social Psychiatry and Psychiatric Epidemiology·Phoenix K H Mo, Winnie W S Mak
Jul 30, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Siegfried GeyerMechthild Neises
Mar 22, 2013·Journal of Psychosocial Oncology·Anette Fischer PedersenPeter Vedsted
Jul 28, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alice E SimonJane Wardle
Apr 19, 2011·BMC Cancer·Bachok Norsa'adahBiswa M Biswal
Jan 1, 2013·BMC Cancer·Karla Unger-SaldañaClaudia Infante-Castañeda
Aug 2, 2011·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Peter Vedsted, Frede Olesen
May 31, 2014·World Journal of Gastroenterology : WJG·Zuhir BodalalRiyad Bendardaf
Sep 1, 2012·Women's Health·Sandra C Jones, Keryn Johnson
Apr 14, 2011·Journal of Women's Health·Rose C MalyAmardeep Thind
Dec 19, 2014·European Journal of Cancer Care·D V OberoiJ de Nooijer
May 21, 2008·Patient Education and Counseling·Jennifer D AllenRoberta E Goldman
Mar 8, 2016·European Journal of Cancer Care·Colleen WebberPatti A Groome
Oct 3, 2007·Journal of the American Geriatrics Society·Miriam B Rodin, Supriya G Mohile
Apr 28, 2012·British Journal of Health Psychology·S E ScottJ Emery
Jun 5, 2013·European Journal of Cancer Care·J Chatwin, C Sanders
Oct 27, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Bachok Norsa'adahAishah Knight
Jan 28, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Ummugul UyeturkHasan Ergenc
Jul 9, 2003·BMC Women's Health·Ali MontazeriAkram Sajadian
Aug 19, 2014·BMC Cancer·Charlotte VrintenJane Wardle
Mar 19, 2011·Journal of Health Psychology·Karen FergusAndrea Eisen
May 25, 2013·Chronic Illness·Alice S ForsterAmanda-Jane Ramirez
Aug 13, 2014·World Journal of Clinical Oncology·Karla Unger-Saldaña
Jan 9, 2019·British Journal of Nursing : BJN·Aradhna KaushalLindsay J Forbes
Oct 6, 2018·Indian Journal of Surgical Oncology·Bhagwan M NeneRengaswamy Sankaranarayanan
May 7, 2019·International Journal of Breast Cancer·Francis AgbokeyKwaku Poku Asante
Jul 10, 2019·Health Psychology Review·Dafina PetrovaMiguel Rodríguez-Barranco
May 20, 2008·International Journal of Cancer. Journal International Du Cancer·Rianne de GelderHarry J de Koning
Mar 13, 2015·Iranian Red Crescent Medical Journal·Sedigheh PaksereshtNahid Sarafraz
Jun 10, 2016·British Journal of Cancer·Maja NiksicLindsay J L Forbes
Oct 8, 2019·The British Journal of Psychiatry : the Journal of Mental Science·Robert StewartArnstein Mykletun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.